free性video西欧极品,伊人依成久久人综合网,中文字幕人妻一区二区三区熟女,男女高潮激烈无遮挡免费观软件 ,成人3d动漫一区二区三区

Company Profile

Year Established : 1962
Total Assets(USD) : 500,000 to 99,999,999
Total Number of Staff : 100-500
Main Competitive Advantages : Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Buyers' Specifications Accepted,Reputation,Quality Service
Patents and Copyrights : ?Ferric Carboxymaltose – Patent No. 370845 & 434424; ?Iron-Isomaltoside – Patent No. 381772; ?Iron (III) Coordination Complex – Patent No. 412127; ?Ferric Derisomaltose – Patent No. 388898; ?Ferric Citrate – Patent No. 356552; ?Sucroferric Oxyhydroxide – Patent No. 419785; ?Enclomiphene Citrate – Patent No. 389779; ?Ferric Maltol – Patent No. 538762; ?Ferric Carboxymaltose- Patent No. 566196; ?Iron Polymaltose Complex - Patent No. 567102.
  • Contact Person :
  • Fax:

West Bengal Chemical Industries Limited (WBCIL) is a globally recognized name in the field of Active Pharmaceutical Ingredients (APIs), fine chemicals, and nutraceuticals. With a heritage of over 60 years, WBCIL has earned a reputation for chemical innovation, quality, and manufacturing excellence. Our integrated production facilities in Kolkata (West Bengal) and Dahej (Gujarat) are state-of-the-art and certified by WHO-GMP, ISO, HACCP, and GLP, reflecting our unwavering commitment to international quality and regulatory compliance.

 

At CPhI China 2025, WBCIL is proud to present its advanced pharmaceutical and nutraceutical portfolio, emphasizing innovation-driven solutions with a focus on Liposomal and Chelated Mineral APIs.

 

Key Product Segments:

  • Liposomal Minerals & Vitamins:

Our next-generation liposomal technologies improve bioavailability, absorption, and stability of nutrients. We offer a wide range of liposomal ingredients including Iron, Calcium, Magnesium, Zinc, Vitamin C, D3, K2, B1, B6, and B12, ideal for supplements, functional foods, and therapeutic formulations.

 

  • Injectable Iron APIs:

WBCIL manufactures high-purity injectable iron formulations such as Iron Isomaltoside, Iron Polymaltose, and Ferric Carboxymaltose, known for high absorption efficiency and minimal gastrointestinal discomfort, particularly effective for treating iron deficiency anemia.

 

  • Mineral Chelates:

Our chelated minerals—Ferrous Bisglycinate, Magnesium Bisglycinate, and Calcium Pidolate—offer enhanced bioavailability and tolerance, supporting bone health, metabolic functions, and immune wellness.

 

  • Liposomal Dietary Supplements:

Featuring science-backed actives like Liposomal Alpha Lipoic Acid, Curcumin, and Glutathione, our formulations target oxidative stress, inflammation, and detoxification.

 

  • Liposomal Cosmeceuticals:

Our dermal-grade ingredients such as Liposomal Ascorbic Acid, Hyaluronic Acid, and Niacinamide cater to skincare, anti-aging, and hydration-focused formulations.

 

In addition to its manufacturing capabilities, WBCIL is actively seeking dependable partners for the procurement of key raw materials, including citric acid, butyric acid, glycine, and pyroglutamic acid, vital to our expanding nutraceutical lines.

 

Operating in over 30 countries, WBCIL invites distributors, formulation partners, and raw material suppliers to explore collaborative opportunities. Together, we can create next-generation solutions in healthcare and wellness.

 

Join us at Booth E1D40, CPhI China 2025, at the Shanghai New International Expo Centre (SNIEC) from June 24–26, and experience the future of liposomal and mineral API innovation.

PharmaSources Customer Service